E
PMGC Holdings Inc. ELAB
$4.93 -$0.11-2.18%
Recommendation
Sell
Prev Close
$5.04
Volume
123,639
Avg Vol (90D)
280,835
Market Cap
$2.91M
Dividend & Yield
--
52-Week Range
$4.39 - $1,161.72
P/E (TTM)
--
EPS (TTM)
-$315.80
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Is PMGC Holdings (NASDAQ:ELAB) In A Good Position To Invest In Growth?
3/10/2025 - Simply Wall St
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
3/10/2025 - Globe Newswire
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
3/6/2025 - Globe Newswire
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group
2/27/2025 - Globe Newswire
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market
2/26/2025 - Globe Newswire
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists
2/18/2025 - Globe Newswire
Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1
2/4/2025 - Globe Newswire
PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies
1/31/2025 - Globe Newswire
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
1/30/2025 - Globe Newswire
Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)
1/28/2025 - Globe Newswire
PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors
1/27/2025 - Globe Newswire
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium
1/24/2025 - Globe Newswire
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture
1/16/2025 - Globe Newswire
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries
1/15/2025 - Globe Newswire
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy
1/2/2025 - Globe Newswire
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
1/2/2025 - Globe Newswire
2025 Startups to Watch: Elevai Labs Inc.
1/2/2025 - BizJournals.com - Nat'l Business News
Elevai Labs (NASDAQ:ELAB) Announces Resignation of Director
12/31/2024 - Ticker Report
Elevai Labs (NASDAQ: ELAB) Dismisses TPS Thayer, LLC as Independent Registered Public Accounting Firm
12/24/2024 - Ticker Report
Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada
12/21/2024 - GuruFocus
Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada
12/21/2024 - GuruFocus
Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada
12/21/2024 - Globe Newswire
Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada
12/20/2024 - GuruFocus
Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada
12/20/2024 - TipRanks Financial Blog
Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada
12/20/2024 - The Fly
Income Statement
Total Revenue (TTM)
$2.45M
EBITDA (TTM)
-$4.88M
EBIT (TTM)
-$4.94M
Net Income (TTM)
-$5.47M
Balance Sheet
Total Assets (Q)
$11.21M
Total Debt (Q)
$103.30K
Total Liabilities (Q)
$2.65M
Book Value Per Share (Q)
$242.57
Cash Flow
Cash from Operations (TTM)
-$5.87M
Cash from Investing (TTM)
-$171.50K
Cash from Financing (TTM)
$12.00M
Net Change in Cash (TTM)
$5.95M
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-40.82%
30-Day Total Return
-77.28%
60-Day Total Return
-66.46%
90-Day Total Return
-96.52%
Year to Date Total Return
-71.60%
1-Year Total Return
-99.54%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Mar 07, 2025 - $4.39
52-week High
Mar 11, 2024 - $1,161.72
Valuation
Market Cap
$2.91M - Nano Cap
Enterprise Value
-$3.55M
Price/Sales (TTM)
0.03
Price/Book (Q)
0.02
Dividends and Shares
Shares Outstanding
15.80K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
pmgcholdings.com
Phone Number
866-794-4940
Address
120 Newport Center Drive
Newport Beach, CA 92660
Country
United States
Year Founded
2020
Business Description
Sector
Consumer Staples
Industry
Household and Personal Products
PMGC Holdings Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care... more
NASDAQ 03/10/2025 11:06AM Eastern Quotes delayed
Weiss Ratings